Opinion

Video

Best Practices for Biomarker Testing in Metastatic Melanoma

When a patient with metastatic melanoma patient tests negative for the BRAF V600E mutation, doctors recommend sending the sample for next-generation sequencing testing which can take 2-3 weeks, during which time they may start immunotherapy if the patient has aggressive disease, but ideally should wait for results to guide treatment.

Related Videos
Michael A. Postow, MD
Matthew P. Deek, MD